This inventor holds 2 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 2001-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2003
Title: Maria-Luisa Rodriguez: Innovator in Pharmaceutical Sciences
Introduction
Maria-Luisa Rodriguez is a prominent inventor based in Erkrath, Germany. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative treatments for various medical conditions. With a total of 2 patents to her name, her work has the potential to impact the lives of many patients.
Latest Patents
Rodriguez's latest patents include the "Repinotan kit" and the "Use of efomycins." The Repinotan kit involves a pharmaceutical composition containing repinotan or a physiologically acceptable salt of repinotan, along with a means for determining the concentration of repinotan or its metabolites in body fluids. This invention also encompasses new pharmaceutical compositions containing repinotan and processes for their preparation. The second patent, related to the use of efomycins, focuses on their application in treating autoimmune disorders. It introduces new natural substances efomycins M and T, along with processes for their preparation, particularly for use as medicaments in psoriasis therapy.
Career Highlights
Maria-Luisa Rodriguez is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical company. Her work at Bayer has allowed her to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Rodriguez has worked alongside notable colleagues such as Werner Kroll and Ferdinand Rombout. These collaborations have further enhanced her research capabilities and have led to the advancement of innovative solutions in the pharmaceutical industry.
Conclusion
Maria-Luisa Rodriguez is a remarkable inventor whose contributions to pharmaceutical sciences are noteworthy. Her patents reflect her dedication to improving medical treatments and her commitment to innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
